Mallinckrodt PLC | Mutual Funds
Mutual Funds that own Mallinckrodt PLC
iShares Core S&P Mid Cap ETF
2,271,477
2.73%
1,836
0.16%
09/06/2018
Vanguard Small Cap Index Fund
2,091,731
2.5%
29,894
0.07%
07/31/2018
Vanguard Total Stock Market Index Fund
2,077,116
2.5%
27,896
0.01%
07/31/2018
Government Pension Fund - Global (The)
1,768,023
2.13%
919,471
0.01%
12/31/2017
iShares Russell 2000 ETF
1,736,711
2.09%
-927
0.12%
09/06/2018
DFA US Small Cap Value Portfolio
1,590,154
1.91%
105,717
0.27%
04/30/2018
Hotchkis & Wiley Mid Cap Value Fund
1,555,400
1.87%
0
2.77%
07/31/2018
Vanguard Small Cap Value Index Fund
1,314,896
1.58%
16,490
0.14%
07/31/2018
Fidelity Value Fund
1,291,207
1.55%
150,407
0.55%
07/31/2018
Vanguard Extended Market Index Fund
1,097,969
1.32%
35,284
0.05%
07/31/2018
| Address |
3 Lotus Park
Staines-Upon-Thames Surrey TW18 3AG
United Kingdom
|
|
Employees
|
- |
| Website |
http://mallinckrodt.com |
| Updated |
07/08/2019 |
| Mallinckrodt Plc operates as a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. |
